Bevirimat

Bevirimat (research code MPC-4326) is an anti-HIV drug derived from a betulinic acid-like compound, first isolated from Syzygium claviflorum, a Chinese herb. It is believed to inhibit HIV by a novel mechanism, so-called maturation inhibition. It is not currently U.S. Food and Drug Administration (FDA) approved. It was originally developed by the pharmaceutical company Panacos and reached Phase IIb clinical trials. Myriad Genetics announced on January 21, 2009 the acquisition of all rights to bevirimat for $7M USD. On June 8, 2010 Myriad Genetics announced that it was halting the development of maturation inhibitors, including bevirimat, to focus more on their oncology portfolio.

单词	Bevirimat
释义	Bevirimat 英语百科 Bevirimat Bevirimat (research code MPC-4326) is an anti-HIV drug derived from a betulinic acid-like compound, first isolated from Syzygium claviflorum, a Chinese herb. It is believed to inhibit HIV by a novel mechanism, so-called maturation inhibition. It is not currently U.S. Food and Drug Administration (FDA) approved. It was originally developed by the pharmaceutical company Panacos and reached Phase IIb clinical trials. Myriad Genetics announced on January 21, 2009 the acquisition of all rights to bevirimat for $7M USD. On June 8, 2010 Myriad Genetics announced that it was halting the development of maturation inhibitors, including bevirimat, to focus more on their oncology portfolio.
随便看	Oxabolone cipionate Oxabolone cypionate oxabrexine Oxacefamandole oxacephalosporin oxacephalosporins Oxacephalothin Oxacephem oxacephem antibiotics oxacephems Oxaceprol oxachelin oxacid oxacilinum natricum oxacillin oxacillinase oxacillinases oxacilline sodium Oxacillin measurement Oxacillin,Monosodium Salt,Anhydrous Oxacillin,Monosodium Salt,Monohydrate Oxacillin,Sodium Oxacillin sodium Oxacillin Sodium Capsules Oxacillin Sodium For Injection